Approach to the diagnosis of portal hypertension.
作者信息
Koh Christopher, Heller Theo
机构信息
Translational Hepatology Unit, Liver Diseases Branch, National Institute of Diabetes & Digestive & Kidney Diseases, National Institutes of Health, Bethesda, MD.
出版信息
Clin Liver Dis (Hoboken). 2012 Nov 9;1(5):133-135. doi: 10.1002/cld.78. eCollection 2012 Nov.
Abstract
摘要
相似文献
1
Approach to the diagnosis of portal hypertension.
Clin Liver Dis (Hoboken). 2012 Nov 9;1(5):133-135. doi: 10.1002/cld.78. eCollection 2012 Nov.
2
Noncirrhotic portal hypertension.
Curr Opin Gastroenterol. 2018 May;34(3):140-145. doi: 10.1097/MOG.0000000000000433.
3
A Meta-analysis of the Value of vWF in the Diagnosis of Liver Cirrhosis with Portal Hypertension.
J Clin Transl Hepatol. 2019 Mar 28;7(1):3-8. doi: 10.14218/JCTH.2018.00036. Epub 2018 Nov 12.
4
Choledochal cyst associated with portal hypertension.
Pediatr Surg Int. 2003 Dec;19(11):729-32. doi: 10.1007/s00383-003-1059-5. Epub 2003 Dec 24.
5
Pre-operative angiographic assessment of portal venous hypertension.
S Afr Med J. 1977 Jul 16;52(3):103-7.
6
[Expert consensus on diagnosis and treatment of esophagogastric variceal bleeding in cirrhotic portal hypertension (2019 edition)].
Zhonghua Wai Ke Za Zhi. 2019 Dec 1;57(12):885-892. doi: 10.3760/cma.j.issn.0529-5815.2019.12.002.
7
[Clinical approach to portal hypertension].
An Med Interna. 2000 Sep;17(9):496-503.
8
9
Portal hypertension in children: expert pediatric opinion on the report of the Baveno v Consensus Workshop on Methodology of Diagnosis and Therapy in Portal Hypertension.
Pediatr Transplant. 2012 Aug;16(5):426-37. doi: 10.1111/j.1399-3046.2012.01652.x. Epub 2012 Mar 13.
10
[Focusing on the diagnosis and management of portal hypertension in cirrhosis].
Zhonghua Gan Zang Bing Za Zhi. 2017 Jun 20;25(6):401. doi: 10.3760/cma.j.issn.1007-3418.2017.06.001.
引用本文的文献
1
Index Hepatic Decompensation: Hepatic Hydrothorax Without Signs of Clinically Significant Portal Hypertension Diagnosed With Radioisotope Scintigraphy.
ACG Case Rep J. 2025 Sep 4;12(9):e01819. doi: 10.14309/crj.0000000000001819. eCollection 2025 Sep.
2
Utility of splenic transient elastography in assessing the presence of portal hypertension: A review.
World J Methodol. 2025 Dec 20;15(4):107411. doi: 10.5662/wjm.v15.i4.107411.
3
Activation of MEK-ERK-c-MYC signaling pathway promotes splenic M2-like macrophage polarization to inhibit PHcH-liver cirrhosis.
Front Immunol. 2024 Nov 8;15:1417521. doi: 10.3389/fimmu.2024.1417521. eCollection 2024.
4
Estimation of Physiologic Pressures: Invasive and Non-Invasive Techniques, AI Models, and Future Perspectives.
Sensors (Basel). 2023 Jun 20;23(12):5744. doi: 10.3390/s23125744.
5
Current clinical understanding and effectiveness of portopulmonary hypertension treatment.
Front Med (Lausanne). 2023 Apr 4;10:1142836. doi: 10.3389/fmed.2023.1142836. eCollection 2023.
6
β-arrestin-2 predicts the clinical response to β-blockers in cirrhotic portal hypertension patients: A prospective study.
World J Hepatol. 2022 Feb 27;14(2):429-441. doi: 10.4254/wjh.v14.i2.429.
7
An Uncommon Cause of Hematemesis.
Clin Liver Dis (Hoboken). 2021 Apr 13;17(3):174-179. doi: 10.1002/cld.1015. eCollection 2021 Mar.
8
Development of a method for measuring spleen stiffness by transient elastography using a new device and ultrasound-fusion method.
PLoS One. 2021 Feb 4;16(2):e0246315. doi: 10.1371/journal.pone.0246315. eCollection 2021.
9
Atypical Sarcoidosis Diagnosed by Massive Splenomegaly.
Intern Med. 2020 Mar 1;59(5):641-648. doi: 10.2169/internalmedicine.3646-19. Epub 2019 Oct 31.
10
Screening for esophageal varices.
Clin Liver Dis (Hoboken). 2012 Nov 9;1(5):143-146. doi: 10.1002/cld.101. eCollection 2012 Nov.
本文引用的文献
1
Non invasive evaluation of portal hypertension using transient elastography.
J Hepatol. 2012 Mar;56(3):696-703. doi: 10.1016/j.jhep.2011.07.005. Epub 2011 Jul 20.
2
Idiopathic noncirrhotic portal hypertension.
Hepatology. 2011 Sep 2;54(3):1071-81. doi: 10.1002/hep.24422. Epub 2011 Jul 21.
3
Noninvasive assessment of portal hypertension in patients with cirrhosis.
Hepatology. 2011 Feb;53(2):683-94. doi: 10.1002/hep.24129.
4
Hepatic venous pressure gradient predicts development of hepatocellular carcinoma independently of severity of cirrhosis.
J Hepatol. 2009 May;50(5):923-8. doi: 10.1016/j.jhep.2009.01.014. Epub 2009 Mar 5.
5
Portal hypertension and its complications.
Gastroenterology. 2008 May;134(6):1715-28. doi: 10.1053/j.gastro.2008.03.007.
6
Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis.
Gastroenterology. 2007 Aug;133(2):481-8. doi: 10.1053/j.gastro.2007.05.024. Epub 2007 May 21.
7
Influence of portal hypertension and its early decompression by TIPS placement on the outcome of variceal bleeding.
Hepatology. 2004 Oct;40(4):793-801. doi: 10.1002/hep.20386.
8
Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure.
Gastroenterology. 1996 Oct;111(4):1018-22. doi: 10.1016/s0016-5085(96)70070-7.
9
Portal pressure, presence of gastroesophageal varices and variceal bleeding.
Hepatology. 1985 May-Jun;5(3):419-24. doi: 10.1002/hep.1840050313.
Zotero 插件